EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

PURPOSE: Approximately 3% to 10% of EGFR (epidermal growth factor receptor) -mutant non–small cell lung cancers (NSCLCs) undergo transformation to small-cell lung cancer (SCLC), but their clinical course is poorly characterized. METHODS: We retrospectively identified patients with EGFR-mutant SCLC a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Marcoux, Nicolas, Gettinger, Scott N., O’Kane, Grainne, Arbour, Kathryn C., Neal, Joel W., Husain, Hatim, Evans, Tracey L., Brahmer, Julie R., Muzikansky, Alona, Bonomi, Philip D., del Prete, Salvatore, Wurtz, Anna, Farago, Anna F., Dias-Santagata, Dora, Mino-Kenudson, Mari, Reckamp, Karen L., Yu, Helena A., Wakelee, Heather A., Shepherd, Frances A., Piotrowska, Zofia, Sequist, Lecia V.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
RAPID COMMUNICATIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001776/
https://ncbi.nlm.nih.gov/pubmed/30550363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados